The story of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the drug arena . While its groundbreaking success and impact of vast in earnings , the exclusivity end has opened the floodgates for generic medications, significantly eroding earnings prospects . This shift raises doubts about the future vi